MedPath

Development and Validation of Safety of a New Antimicrobial Agent Therapy to early healing for Individual Periodontal Disease

Not Applicable
Conditions
Periodontitis
Registration Number
JPRN-UMIN000012033
Lead Sponsor
Department of Periodontology, Tsurumi University School of Dental Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with any systemic illness known to affect the outcomes of periodontal treatment 2) Pregnancy and/or lactation 3) Smoker 4) Other(Doctors dicision)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Primary Outcome of this Study is to Evaluate the Efficacy for New Antimicrobial Agent Therapy for Periodontal Disease Patient.
Secondary Outcome Measures
NameTimeMethod
The Secondary Outcome of this Study is to Evaluate the Safety for New Antimicrobial Agent Therapy for Periodontal Disease Patient.
© Copyright 2025. All Rights Reserved by MedPath